TrialCalcified tissue international2016

Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan.

Daisuke Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.